
Advanced Cell is a new advanced bone grafting and fusion convenience kit that offers multiple solutions to achieve optimal results in a variety of settings. Advanced Cell offers 3 unique technologies all in one convenience kit that have the ability to enhance clinical outcomes.

Advanced Cell is a new advanced bone grafting and fusion convenience kit that offers multiple solutions to achieve optimal results in a variety of settings. Advanced Cell offers 3 unique technologies all in one convenience kit that have the ability to enhance clinical outcomes.
Advanced Cell offers the ability to harness the power of each patients own live cells and combine with autograft and advanced bone grafting solutions, point of care. Advanced Cell streamlines OR time and optimizes workflow all while providing low costs solutions for providers.


Aspirating Bone Marrow from multiple locations allows for the maximum amount of progenitor stem cells are collected, without the dilution or collection of peripheral blood.

Optimal Components



The Perfect Trio

Indications for Use
The device is to be gently packed into bony voids or gaps of the skeletal system (i.e., posterolateral spine). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The device resorbs and is replaced with bone during the natural healing process.
Autograft Harvesting System





SOURCES
- https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011783/full accessed on 13 Nov 2018.
- Missiuna PC, Gandhi HS, Farrokhyar F, Harnett BE, Dore EM, Roberts B. Anatomically safe and minimally invasive transcrestal technique for procurement of autogenous cancellous bone graft from the mid-iliac crest. Can J Surg. 2011;54(5):327-32.
- Hernigou P, Descroches A, Quennec S, Flousat Lachaniette CH, Poignard A, Allain J, Chevallier N, Rouard H. Morbidity of graft harvesting versus bone marrow aspiration in cell regenerative therapy. Int Orthop. 2014 Sep;38(9):1855-60
- Block JE. The role and effectiveness of bone marrow in osseous regeneration. Med Hypotheses. 2005;65(4):740-7.
- Wang W, Yeung K. Bone grafts and biomaterials substitutes for bone defect repair. A review. Bioactive Materials. 2017;2(4):224-227.
- Bleuming SA, He XC, Kodach LL, Hardwick JC, Koopman FA, Ten Kate FJ, van Deventer SJ, Hommes DW, Peppelenbosch MP, Offerhaus GJ, Li L, van den Brink GR (Sep 2007). “Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice”. Cancer Research. 67 (17): 8149–55.
- Ostrup et al Distant transfer of a free, living bone graft by micro-vascular anastomoses. An experimental study. Plast Reconstr. Surg. 1974 Sep; 54(3): 274-85
Explore our Entire Product Line
Autologous Advanced Biologics
Advanced Synthetics
About Royal
Royal is a pioneering leader in orthobiologic and wound care research and development. Royal’s commitment lies in delivering top-tier, innovative biologic solutions that enhance the healing process and improve patients' quality of life. Royal places patient well-being at the center of its mission, offering exceptional solutions to address a variety of complex needs.
At Royal, our mission is driven by patient-centered care, innovation and excellence, and integrity and compassion. Royal provides a comprehensive array of products tailored to meet the varied needs of the orthobiologic and wound care industry.
As a rapidly expanding force in the industry, Royal is continuously developing and launching new products and solutions that set benchmarks for quality, effectiveness, and patient outcomes. Royal’s commitment to research and innovation keeps it at the forefront of the industry, helping to shape the future of healthcare and improving lives.